Biopolymer marker indicative of disease state having a molecular weight of 1518 daltons
    2.
    发明申请
    Biopolymer marker indicative of disease state having a molecular weight of 1518 daltons 失效
    指示分子量为1518道尔顿的疾病状态的生物聚合物标记物

    公开(公告)号:US20050287599A1

    公开(公告)日:2005-12-29

    申请号:US11144402

    申请日:2005-06-03

    CPC分类号: G01N33/6893

    摘要: The instant invention involves the use of a combination of preparatory steps in conjunction with mass spectroscopy and time-of-flight detection procedures to maximize the diversity of biopolymers which are verifiable within a particular sample. The cohort of biopolymers verified within such a sample is then viewed with reference to their ability to evidence at least one particular disease state; thereby enabling a diagnostician to gain the ability to characterize either the presence or absence of said at least one disease state relative to recognition of the presence and/or the absence of said biopolymer.

    摘要翻译: 本发明涉及使用组合的准备步骤与质谱法和飞行时间检测程序的组合,以使特定样品中可验证的生物聚合物的多样性最大化。 然后,在这样一个样本中验证的生物聚合物队列参照其证明至少一种特定疾病状态的能力; 从而使得诊断者能够获得表征所述至少一种疾病状态的存在或不存在与识别所述生物聚合物的存在和/或不存在的能力。

    Biopolymer marker indicative of disease state having a molecular weight of 1,896 daltons
    3.
    发明授权
    Biopolymer marker indicative of disease state having a molecular weight of 1,896 daltons 失效
    指示分子量为1,896道尔顿的疾病状态的生物聚合物标记物

    公开(公告)号:US06703366B2

    公开(公告)日:2004-03-09

    申请号:US09846343

    申请日:2001-04-30

    IPC分类号: A61K3800

    摘要: The instant invention involves the use of a combination of preparatory steps in conjunction with mass spectroscopy and time-of-flight detection procedures to maximize the diversity of biopolymers which are verifiable within a particular sample. The cohort of biopolymers verified within such a sample is then viewed with reference to their ability to evidence at least one particular disease state; thereby enabling a diagnostician to gain the ability to characterize either the presence or absence of said at least one disease state relative to recognition of the presence and/or the absence of said biopolymer.

    摘要翻译: 本发明涉及使用组合的准备步骤与质谱法和飞行时间检测程序的组合,以使特定样品中可验证的生物聚合物的多样性最大化。 然后,在这样一个样本中验证的生物聚合物队列参照其证明至少一种特定疾病状态的能力; 从而使得诊断者能够获得表征所述至少一种疾病状态的存在或不存在与识别所述生物聚合物的存在和/或不存在的能力。

    Biopolymer marker indicative of disease state having a molecular weight of 1562 daltons
    5.
    发明授权
    Biopolymer marker indicative of disease state having a molecular weight of 1562 daltons 失效
    指示分子量为1562道尔顿的疾病状态的生物聚合物标记物

    公开(公告)号:US07314717B2

    公开(公告)日:2008-01-01

    申请号:US09845738

    申请日:2001-04-30

    IPC分类号: G01N33/53 G01N33/566

    摘要: The instant invention involves the use of a combination of preparatory steps in conjunction with mass spectroscopy and time-of-flight detection procedures to maximize the diversity of biopolymers which are verifiable within a particular sample. The cohort of biopolymers verified within such a sample is then viewed with reference to their ability to evidence at least one particular disease state; thereby enabling a diagnostician to gain the ability to characterize either the presence or absence of at least one disease state relative to recognition of the presence and/or the absence of the biopolymer.

    摘要翻译: 本发明涉及使用组合的准备步骤与质谱法和飞行时间检测程序的组合,以使特定样品中可验证的生物聚合物的多样性最大化。 然后,在这样一个样本中验证的生物聚合物队列参照其证明至少一种特定疾病状态的能力; 从而使诊断者能够获得表征与识别生物聚合物的存在和/或不存在相关的存在或不存在至少一种疾病状态的能力。

    Biopolymer marker indicative of disease state having a molecular weight of 1525 daltons
    6.
    发明申请
    Biopolymer marker indicative of disease state having a molecular weight of 1525 daltons 失效
    指示分子量为1525道尔顿的疾病状态的生物聚合物标记物

    公开(公告)号:US20060024671A1

    公开(公告)日:2006-02-02

    申请号:US11241443

    申请日:2005-09-30

    IPC分类号: C12Q1/70

    摘要: The instant invention involves the use of a combination of preparatory steps in conjunction with mass spectroscopy and time-of-flight detection procedures to maximize the diversity of biopolymers which are verifiable within a particular sample. The cohort of biopolymers verified within such a sample is then viewed with reference to their ability to evidence at least one particular disease state; thereby enabling a diagnostician to gain the ability to characterize either the presence or absence of said at least one disease state relative to recognition of the presence and/or the absence of said biopolymer.

    摘要翻译: 本发明涉及使用组合的准备步骤与质谱法和飞行时间检测程序的组合,以使特定样品中可验证的生物聚合物的多样性最大化。 然后,在这样一个样本中验证的生物聚合物队列参照其证明至少一种特定疾病状态的能力; 从而使得诊断者能够获得表征所述至少一种疾病状态的存在或不存在与识别所述生物聚合物的存在和/或不存在的能力。

    Biopolymer marker indicative of disease state having a molecular weight of 2021 daltons
    7.
    发明授权
    Biopolymer marker indicative of disease state having a molecular weight of 2021 daltons 失效
    指示分子量为2021道尔顿的疾病状态的生物聚合物标记物

    公开(公告)号:US06756476B2

    公开(公告)日:2004-06-29

    申请号:US09846344

    申请日:2001-04-30

    IPC分类号: C07K700

    摘要: The instant invention involves the use of a combination of preparatory steps in conjunction with mass spectroscopy and time-of-flight detection procedures to maximize the diversity of biopolymers which are verifiable within a particular sample. The cohort of biopolymers verified within such a sample is then viewed with reference to their ability to evidence at least one particular disease state; thereby enabling a diagnostician to gain the ability to characterize either the presence or absence of said at least one disease state relative to recognition of the presence and/or the absence of said biopolymer.

    摘要翻译: 本发明涉及使用组合的准备步骤与质谱法和飞行时间检测程序的组合,以使特定样品中可验证的生物聚合物的多样性最大化。 然后,在这样一个样本中验证的生物聚合物队列参照其证明至少一种特定疾病状态的能力; 从而使得诊断者能够获得表征所述至少一种疾病状态的存在或不存在与识别所述生物聚合物的存在和/或不存在的能力。

    Biopolymer marker indicative of disease state having a molecular weight of 1845 daltons
    8.
    发明授权
    Biopolymer marker indicative of disease state having a molecular weight of 1845 daltons 失效
    指示分子量为1845道尔顿的疾病状态的生物聚合物标记物

    公开(公告)号:US06627607B2

    公开(公告)日:2003-09-30

    申请号:US09846351

    申请日:2001-04-30

    IPC分类号: A61K3800

    摘要: The instant invention involves the use of a combination of preparatory steps in conjunction with mass spectroscopy and time-of-flight detection procedures to maximize the diversity of biopolymers which are verifiable within a particular sample. The cohort of biopolymers verified within such a sample is then viewed with reference to their ability to evidence at least one particular disease state; thereby enabling a diagnostician to gain the ability to characterize either the presence or absence of said at least one disease state relative to recognition of the presence and/or the absence of said biopolymer.

    摘要翻译: 本发明涉及使用组合的准备步骤与质谱法和飞行时间检测程序的组合,以使特定样品中可验证的生物聚合物的多样性最大化。 然后,在这样一个样本中验证的生物聚合物队列参照其证明至少一种特定疾病状态的能力; 从而使得诊断者能够获得表征所述至少一种疾病状态的存在或不存在与识别所述生物聚合物的存在和/或不存在的能力。

    Biopolymer marker indicative of disease state having a molecular weight of 1348 daltons
    9.
    发明授权
    Biopolymer marker indicative of disease state having a molecular weight of 1348 daltons 失效
    指示分子量为1348道尔顿的疾病状态的生物聚合物标记物

    公开(公告)号:US07294688B2

    公开(公告)日:2007-11-13

    申请号:US09845715

    申请日:2001-04-30

    IPC分类号: A51K38/10

    CPC分类号: G01N33/6893

    摘要: The instant invention involves the use of a combination of preparatory steps in conjunction with mass spectroscopy and time-of-flight detection procedures to maximize the diversity of biopolymers which are verifiable within a particular sample. The cohort of biopolymers verified within such a sample is then viewed with reference to their ability to evidence at least one particular disease state; thereby enabling a diagnostician to gain the ability to characterize either the presence or absence of at least one disease state relative to recognition of the presence and/or the absence of the biopolymer.

    摘要翻译: 本发明涉及使用组合的准备步骤与质谱法和飞行时间检测程序的组合,以使特定样品中可验证的生物聚合物的多样性最大化。 然后,在这样一个样本中验证的生物聚合物队列参照其证明至少一种特定疾病状态的能力; 从而使诊断者能够获得表征与识别生物聚合物的存在和/或不存在相关的存在或不存在至少一种疾病状态的能力。

    Biopolymer marker indicative of disease state having a molecular weight of 2753 daltons
    10.
    发明授权
    Biopolymer marker indicative of disease state having a molecular weight of 2753 daltons 失效
    指示分子量为2753道尔顿的疾病状态的生物聚合物标记物

    公开(公告)号:US07087435B2

    公开(公告)日:2006-08-08

    申请号:US09846328

    申请日:2001-04-30

    IPC分类号: G06F19/00 G01N33/48

    摘要: The instant invention involves the use of a combination of preparatory steps in conjunction with mass spectroscopy and time-of-flight detection procedures to maximize the diversity of biopolymers which are verifiable within a particular sample. The cohort of biopolymers verified within such a sample is then viewed with reference to their ability to evidence at least one particular disease state; thereby enabling a diagnostician to gain the ability to characterize either the presence or absence of at least one disease state relative to recognition of the presence and/or the absence of the biopolymer.

    摘要翻译: 本发明涉及使用组合的准备步骤与质谱法和飞行时间检测程序的组合,以使特定样品中可验证的生物聚合物的多样性最大化。 然后,在这样一个样本中验证的生物聚合物队列参照其证明至少一种特定疾病状态的能力; 从而使诊断者能够获得表征与识别生物聚合物的存在和/或不存在相关的存在或不存在至少一种疾病状态的能力。